Belpointe Asset Management’s iShares US Healthcare Providers ETF IHF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,940
Closed -$195K 1881
2023
Q1
$195K Sell
3,940
-2,550
-39% -$131K 0.01% 954
2022
Q4
$347K Buy
6,490
+110
+2% +$5.91K 0.02% 673
2022
Q3
$326K Sell
6,380
-140
-2% -$7.59K 0.02% 659
2022
Q2
$334K Buy
6,520
+70
+1% +$3.73K 0.02% 633
2022
Q1
$365K Sell
6,450
-375
-5% -$20.6K 0.02% 643
2021
Q4
$396K Sell
6,825
-20
-0.3% -$1.09K 0.02% 600
2021
Q3
$351K Buy
6,845
+395
+6% +$21.1K 0.02% 629
2021
Q2
$344K Buy
6,450
+1,000
+18% +$52.8K 0.02% 624
2021
Q1
$275K Sell
5,450
-2,500
-31% -$122K 0.02% 625
2020
Q4
$373K Buy
7,950
+5,050
+174% +$224K 0.03% 484
2020
Q3
$117K Sell
2,900
-425
-13% -$17.2K 0.01% 719
2020
Q2
$128K Sell
3,325
-75
-2% -$2.83K 0.02% 652
2020
Q1
$113K Buy
+3,400
New +$129K 0.02% 578

Other funds holding IHF

Belpointe Asset Management's IHF Position: Q2 2023 in Review

Belpointe Asset Management sold out of iShares US Healthcare Providers ETF (IHF) in Q2 2023, closing a stake of 3,940 shares — an estimated $195K sold.

Belpointe Asset Management first reported a position in IHF in Q1 2020 and held it in 13 quarters. The position peaked at $396K in Q4 2021. 209 funds tracked by Wall St. Rank hold IHF as of Q2 2023.

  • Belpointe Asset Management reported no remaining iShares US Healthcare Providers ETF position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 3,940 iShares US Healthcare Providers ETF shares in Q2 2023, an estimated $195K.
  • Belpointe Asset Management first reported a position in iShares US Healthcare Providers ETF in Q1 2020 and held it in 13 quarters.
  • Belpointe Asset Management's iShares US Healthcare Providers ETF position peaked at $396K in Q4 2021.
  • 209 funds tracked by Wall St. Rank held iShares US Healthcare Providers ETF as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.